Mark A. Mintun
M.D.
Medical sciences
Avid Radiopharmaceuticals (Eli Lilly)
Montenegro
Biography
Dr. Mark A. Mintun, MD, has been the Chief Medical Officer of Avid Radiopharmaceuticals, Inc., since August 2010. Dr. Mintun has extensive research, clinical and management experience. He served as Vice Chair for Research and Director of the Center for Clinical Imaging Research at the prestigious Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, MO. He is certified by the American Board of Nuclear Medicine. His research portfolio includes publishing the first report showing PET imaging of brain receptors, development of methods for imaging oxygen metabolism and pioneering techniques for mapping human brain function. His recent work has focused on the use of PET amyloid imaging to identify the earliest pathological changes of Alzheimer's disease. Dr. Mintun holds a Bachelors' degree from MIT and a Medical Degree from Washington University in St. Louis.
Research Interest
Alzheimer's disease
